| PERIOD ENDING | 28-Dec-08 | 30-Dec-07 | 31-Dec-06 | | Total Revenue | 3,351,352 | 3,896,366 | 3,257,525 | | Cost of Revenue | 3,288,265 | 2,693,647 | 2,018,052 | | | Gross Profit | 63,087 | 1,202,719 | 1,239,473 | | | Operating Expenses | | Research Development | 429,949 | 418,066 | 306,866 | | Selling General and Administrative | 532,844 | 476,103 | 363,241 | | Non Recurring | 1,056,705 | 6,728 | 225,600 | | Others | 17,069 | 25,308 | 17,432 | | | | Total Operating Expenses | 2,036,567 | 926,205 | 913,139 | | | | Operating Income or Loss | (1,973,480) | 276,514 | 326,334 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 70,446 | 123,406 | 107,172 | | Earnings Before Interest And Taxes | (1,903,034) | 399,920 | 434,100 | | Interest Expense |
-
| 1,504 | 3,392 | | Income Before Tax | (1,903,034) | 398,416 | 430,708 | | Income Tax Expense | 153,742 | 174,848 | 230,193 | | Minority Interest |
-
| (5,211) | (1,619) | | | | Net Income From Continuing Ops | (2,056,776) | 218,357 | 198,896 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (2,056,776) | 218,357 | 198,896 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,056,776) | $218,357 | $198,896 |
|
0.07% Nasdaq 
Income Statement
